Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-003231-20Phase 4Completed
Phase 4 trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by KU Leuven. Primary endpoint: Post-baseline taking adherence comparison. Started Aug 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-003231-20.